Back to mobile site

More on NAGE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-60.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Niagen Bioscience (NQ:NAGE)
Delayed: 3.04 +0.05 (1.67%)
Prev. Close $2.99  
Open$2.99 
52 Wk High$ 
52 Wk Low$ 
Day High$3.04 
Day Low$2.97 
P/E N/A  
EPS$ 
Volume292,615 

Friends, Peers and Foes (?): CDXC, LEXX, PM, WST, CGC (more...)

Sep 21, 2026 08:32 AM Niagen Bioscience: Study links CD38 enzyme to NAD+ decline in aging placental tissue
Sep 21, 2026 08:32 AM Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (
Sep 18, 2026 06:43 AM Canaccord Reiterates Buy Rating on (NAGE)
Sep 17, 2026 08:32 AM Niagen Bioscience adds advisors for drug development push
Sep 17, 2026 08:32 AM Niagen Bioscience Engages Veteran Pharmaceutical Executives and Biotechnology Experts to Support Drug Development Program and Strategic Business Growth
Sep 10, 2026 08:32 AM Niagen Bioscience to Present at Canaccord Genuity’s Well Summit
Aug 26, 2026 08:32 AM Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit
Aug 24, 2026 06:41 AM Canaccord Reiterates Buy Rating on Niagen Bioscience (NAGE)
Aug 20, 2026 08:32 AM Niagen Bioscience's Tru Niagen now sold at GNC and Sam's Club
Aug 20, 2026 08:32 AM Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club
View All Articles

Entities mentioned with NAGE

View All Entities